Michaela Yip

ORCID: 0000-0002-7637-2746
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer, Hypoxia, and Metabolism
  • Neuroblastoma Research and Treatments
  • Mitochondrial Function and Pathology
  • ATP Synthase and ATPases Research
  • Epigenetics and DNA Methylation
  • Histone Deacetylase Inhibitors Research
  • Genomics, phytochemicals, and oxidative stress
  • Adipose Tissue and Metabolism
  • Autophagy in Disease and Therapy
  • Glioma Diagnosis and Treatment

Columbia University Irving Medical Center
2023

Weatherford College
2023

Stanford University
2020-2022

Despite the fact that Otto H. Warburg discovered effect almost one hundred years ago, why cancer cells waste most of glucose carbon as lactate remains an enigma. proposed a connection between and cell dedifferentiation. Hypoxia is common tumor microenvironmental stress induces blocks differentiation. The underlying mechanism by which this occurs poorly understood, no effective therapeutic strategy has been developed to overcome resistance Using neuroblastoma differentiation model, we hypoxia...

10.1038/s41419-020-2303-9 article EN cc-by Cell Death and Disease 2020-02-06

Abstract The Warburg effect is the major metabolic hallmark of cancer. According to himself, consequence cell dedifferentiation. Therefore, reversing might be an approach restore differentiation in In this study, we used a mitochondrial uncoupler, niclosamide ethanolamine (NEN), activate respiration, which induced neural neuroblastoma cells. NEN treatment increased NAD+/NADH and pyruvate/lactate ratios also α-ketoglutarate/2-hydroxyglutarate (2-HG) ratio. Consequently, promoter CpG island...

10.1158/0008-5472.can-22-1029 article EN Cancer Research 2022-11-01

The interplay between metabolism and chromatin signaling is implicated in cancer progression. However, whether how metabolic reprogramming tumors generates vulnerabilities remain unclear. Lung adenocarcinoma (LUAD) frequently harbor aberrant activation of the NRF2 antioxidant pathway, which drives aggressive chemo-resistant disease. Using a chromatin-focused CRISPR screen, we report that sensitizes LUAD cells to genetic chemical inhibition class I histone deacetylases (HDACs). This...

10.1016/j.celrep.2023.113629 article EN cc-by-nc-nd Cell Reports 2023-12-30

<div>Abstract<p>The Warburg effect is the major metabolic hallmark of cancer. According to himself, consequence cell dedifferentiation. Therefore, reversing might be an approach restore differentiation in In this study, we used a mitochondrial uncoupler, niclosamide ethanolamine (NEN), activate respiration, which induced neural neuroblastoma cells. NEN treatment increased NAD<sup>+</sup>/NADH and pyruvate/lactate ratios also α-ketoglutarate/2-hydroxyglutarate (2-HG)...

10.1158/0008-5472.c.6514392 preprint EN 2023-03-31

<p>Regional counting of differential methylated probes in SK-N-BE(2) cells treated with NEN for 24hrs under nomoxia. Go enrichment pathways the CpG Island promoter (B) (C) and gene body (D) (E)</p>

10.1158/0008-5472.22433538.v1 preprint EN cc-by 2023-03-31

<p>SK-N-BE(2) cells were treated with NEN for 16hrs. (A) Upregulated and (B) downregulated genes from RNA-seq data (n=3) (sleuth q-value < 0.05 fold change estimate b > abs(ln(2))). (C) The top 10 gene ontology (GO) pathways enriched upregulated by using DAVID analysis. (D) analysis.</p>

10.1158/0008-5472.22433541 preprint EN cc-by 2023-03-31

<p>SK-N-BE(2) cells were treated with NEN for 16hrs. (A) Upregulated and (B) downregulated genes from RNA-seq data (n=3) (sleuth q-value < 0.05 fold change estimate b > abs(ln(2))). (C) The top 10 gene ontology (GO) pathways enriched upregulated by using DAVID analysis. (D) analysis.</p>

10.1158/0008-5472.22433541.v1 preprint EN cc-by 2023-03-31

<p>Regional counting of differential methylated probes in SK-N-BE(2) cells treated with NEN for 24hrs under nomoxia. Go enrichment pathways the CpG Island promoter (B) (C) and gene body (D) (E)</p>

10.1158/0008-5472.22433538 preprint EN cc-by 2023-03-31

<p>Favorable and (B) unfavorable gene list (p-value<0.05) from 11 available neuroblastoma databases R2 (https://hgserver1.amc.nl/cgi-bin/r2/main.cgi) (C) Overlapped the favorable prognosis sets (p-value<0.05, number >1000) 7 (https://hgserver1.amc.nl/cgi-bin/r2/main.cgi). (D) (E) Go analysis of overlapped sets. (F) (G) GSEA Favorable genes RNA-seq experiments in Figure (1D).</p>

10.1158/0008-5472.22433535.v1 preprint EN cc-by 2023-03-31

<p>Favorable and (B) unfavorable gene list (p-value<0.05) from 11 available neuroblastoma databases R2 (https://hgserver1.amc.nl/cgi-bin/r2/main.cgi) (C) Overlapped the favorable prognosis sets (p-value<0.05, number >1000) 7 (https://hgserver1.amc.nl/cgi-bin/r2/main.cgi). (D) (E) Go analysis of overlapped sets. (F) (G) GSEA Favorable genes RNA-seq experiments in Figure (1D).</p>

10.1158/0008-5472.22433535 preprint EN cc-by 2023-03-31

<div>Abstract<p>The Warburg effect is the major metabolic hallmark of cancer. According to himself, consequence cell dedifferentiation. Therefore, reversing might be an approach restore differentiation in In this study, we used a mitochondrial uncoupler, niclosamide ethanolamine (NEN), activate respiration, which induced neural neuroblastoma cells. NEN treatment increased NAD<sup>+</sup>/NADH and pyruvate/lactate ratios also α-ketoglutarate/2-hydroxyglutarate (2-HG)...

10.1158/0008-5472.c.6514392.v1 preprint EN 2023-03-31

Abstract Interplay between metabolism and chromatin signaling have been implicated in cancer initiation progression. However, whether how metabolic reprogramming tumors generates specific epigenetic vulnerabilities remain unclear. Lung adenocarcinoma (LUAD) frequently harbor mutations that cause aberrant activation of the NRF2 antioxidant pathway drive aggressive chemo-resistant disease. We performed a chromatin-focused CRISPR screen report sensitized LUAD cells to genetic chemical...

10.1101/2023.04.24.538118 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2023-04-28

Abstract Dysregulated DNA methylation is associated with poor prognosis in cancer patients, promoting tumorigenesis and therapeutic resistance 1 . methyltransferase inhibitors (DNMTi) reduce promote cell differentiation, two DNMTi already approved for treatment 2 However, these drugs rely on division to dilute existing methylation, thus the ‘demethylation’ effects are achieved a passive manner, limiting their application slow-proliferating tumor cells. In this study we use mitochondrial...

10.1101/2021.09.05.459035 preprint EN bioRxiv (Cold Spring Harbor Laboratory) 2021-09-06
Coming Soon ...